Beta blockers and their combinations in the management of hypertension

Ker, James A.

We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.

Show simple item record

dc.contributor.author	Ker, James A.
dc.date.accessioned	2012-11-30T07:12:02Z
dc.date.available	2012-11-30T07:12:02Z
dc.date.issued	2012-09
dc.description.abstract	Beta blockers have been prescribed for the treatment of primary hypertension for a very long time. Currently, it is doubtful whether this is still a good idea. In fact, many are of the opinion that beta blockers should be relegated to a fourth-line drug, if used at all, for the treatment of hypertension. So what happened? Why the change of heart? Basically, two issues are driving this new view of beta blockers.	en_US
dc.description.uri	www.safpj.co.za	en_US
dc.identifier.citation	Ker, JA 2012, 'Beta blockers and their combinations in the management of hypertension', South African Family Practice, vol. 54, no. 5, pp. 409-410.	en_US
dc.identifier.issn	1026-9177 (print)
dc.identifier.issn	1726-426X (online)
dc.identifier.uri	http://hdl.handle.net/2263/20609
dc.language.iso	en	en_US
dc.publisher	South African Academy of Family Practice/Primary Care	en_US
dc.rights	© Medpharm	en_US
dc.subject	Hypertension	en_US
dc.subject.lcsh	Adrenergic beta blockers	en
dc.subject.lcsh	Hypertension -- Treatment	en
dc.subject.lcsh	Cerebrovascular disease	en
dc.title	Beta blockers and their combinations in the management of hypertension	en_US
dc.type	Article	en_US